e-learning
resources
Vienna 2009
Sunday, 13.09.2009
FeNO and other biomarkers in childhood asthma
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Self-reported asthma control correlates with fraction of exhaled nitric oxide and lung function
L. Evaggelidis, J. Konradsen, B. Nordlund, C. Pedroletti, H. Ljungberg (Stockholm, Sweden)
Source:
Annual Congress 2009 - FeNO and other biomarkers in childhood asthma
Session:
FeNO and other biomarkers in childhood asthma
Session type:
Thematic Poster Session
Number:
1200
Disease area:
Airway diseases, Paediatric lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
L. Evaggelidis, J. Konradsen, B. Nordlund, C. Pedroletti, H. Ljungberg (Stockholm, Sweden). Self-reported asthma control correlates with fraction of exhaled nitric oxide and lung function. Eur Respir J 2009; 34: Suppl. 53, 1200
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Related content which might interest you:
In current smokers fraction of exhaled nitric oxide is not associated with asthma symptoms
Source: Annual Congress 2010 - Asthma: breath biomarkers and asthma control
Year: 2010
Bronchodilator response and previous lung function decline in relation with exhaled nitric oxide levels in asthma
Source: International Congress 2017 – Monitoring novel biomarkers in asthma
Year: 2017
Exhaled nitric oxide predicts lung function decline in difficult-to-treat asthma
Source: Eur Respir J 2008; 32: 344-349
Year: 2008
Exhaled nitric oxide and asthma control: a longitudinal study in unselected patients
Source: Eur Respir J 2008; 31: 539-546
Year: 2008
Childhood wheezing phenotypes influence asthma, lung function and exhaled nitric oxide fraction in adolescence
Source: Eur Respir J 2016; 47: 510-519
Year: 2016
Is exhaled nitric oxide (eNO) an indipendent outcome measure in chronic stable asthma?
Source: Eur Respir J 2002; 20: Suppl. 38, 196s
Year: 2002
Exhaled nitric oxide is related to asthma control but not severity
Source: Eur Respir J 2004; 24: Suppl. 48, 260s
Year: 2004
Different relation between exhaled nitric oxide and lung function with regard to current smoking
Source: International Congress 2018 – Epidemiology of asthma, COPD and factors that associate with lung function
Year: 2018
Pulmonary function test and fraction of exhaled nitric oxide of asthma in remission
Source: Annual Congress 2010 - Biomarkers and Diagnosis of asthma and allergic respiratory diseases
Year: 2010
Exhaled nitric oxide as a marker of asthma control in smoking patients
Source: Eur Respir J 2009; 33: 1295-1301
Year: 2009
Combined effects of type 2 inflammation and lung function on exhaled nitric oxide ability to reflect asthma control
Source: International Congress 2019 – FeNO in airway diseases and asthma-COPD overlap identification
Year: 2019
Levels of asthma control and exhaled nitric oxide
Source: Annual Congress 2009 - Airway inflammation and asthma control
Year: 2009
Usefulness of fractional exhaled nitric oxide (FeNO) as a marker of asthma control
Source: Annual Congress 2008 - Phenotyping of asthma and COPD
Year: 2008
The influence of spirometry on the level of exhaled nitric oxide in asthmatic children
Source: Eur Respir J 2003; 22: Suppl. 45, 569s
Year: 2003
Clinical usefulness of fractional exhaled nitric oxide (FeNO) as a marker of long-term asthma control
Source: Annual Congress 2009 - Airway inflammation and asthma control
Year: 2009
Accuracy of exhaled nitric oxide to predict a loss of asthma control in well-controlled patients
Source: Annual Congress 2010 - Biomarkers and Diagnosis of asthma and allergic respiratory diseases
Year: 2010
Exhaled nitric oxide (FeNO) in relation to exacerbation of childhood asthma
Source: Annual Congress 2009 - FeNO and other biomarkers in childhood asthma
Year: 2009
Fractional exhaled nitric oxide is associated with more severe asthma
Source: International Congress 2018 – Biomarkers for evaluating asthma
Year: 2018
Comparison of asthma control test and exhaled nitric oxide to predict asthma control
Source: Annual Congress 2010 - Asthma: breath biomarkers and asthma control
Year: 2010
Comparisons for concentration in exhaled nitric oxide between patients with bronchial asthma and COPD
Source: Annual Congress 2007 - Pathophysiology and assessment of COPD
Year: 2007
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept